Together, our findings reveal a new mechanism of radioresistance in NPC and indicate that targeting the BRD7/METTL3 axis might be a novel therapeutic strategy for NPC radiosensitization. The gene discussed is METTL3; the disease is nasopharyngeal carcinoma.